��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
霹靂(8450)獲利能力分析 季報
單位：百萬
114.1Q
 9.92% (毛利率)
 -73.62% (營益率)
114.1Q
 59百萬 (營業收入)
 53百萬 (營業成本)
 6百萬 (營業毛利)
 -43百萬 (營業利益)
114.1Q
 -47百萬 (稅前淨利)
 -47百萬 (稅後淨利)
114.1Q
 -0.91元 (EPS)
季別 營業收入 營業成本 營業毛利 毛利率 營業利益 營益率 業外收支 稅前淨利 稅後淨利 EPS(元)
114.1Q 59 53 6 9.92% -43 -73.62% -4 -47 -47 -0.91
113.4Q 64 61 3 5.03% -46 -71.62% 19 -27 -39 -0.77
113.3Q 63 46 16 25.99% -32 -51.49% -6 -38 -38 -0.75
113.2Q 64 23 41 63.83% -12 -19.37% 13 0 1 0.02
113.1Q 72 49 23 31.65% -31 -43.12% 28 -3 -3 -0.06
112.4Q 83 101 -18 -22.11% -64 -77.05% -35 -99 -99 -1.92
112.3Q 67 68 -1 -0.89% -62 -92.51% 39 -24 -23 -0.44
112.2Q 76 63 14 17.88% -58 -75.43% 31 -27 -26 -0.52
112.1Q 93 74 19 20.76% -42 -45.29% -0 -43 -42 -0.83
111.4Q 104 87 17 16.11% -47 -45.49% -11 -59 -57 -1.12
111.3Q 98 74 24 24.68% -42 -43.11% 51 9 1 0.01
111.2Q 93 79 13 14.36% -50 -54.32% 24 -26 -29 -0.57
111.1Q 105 92 13 12.16% -55 -52.33% 22 -33 -36 -0.69
110.4Q 115 173 -58 -49.92% -119 -103.39% -4 -124 -123 -2.39
110.3Q 98 76 22 22.79% -40 -41.00% 0 -40 -39 -0.75
110.2Q 107 94 14 12.89% -50 -46.94% -7 -57 -57 -1.11
110.1Q 107 67 40 37.32% -26 -23.99% 8 -18 -18 -0.35
109.4Q 115 123 -7 -6.43% -81 -70.46% -9 -90 -90 -1.75
109.3Q 111 97 14 12.51% -46 -41.84% -11 -58 -52 -1.02
109.2Q 109 58 51 46.50% -14 -13.12% 4 -11 -14 -0.27
109.1Q 130 59 70 54.22% -1 -1.01% 12 10 8 0.15
108.4Q 139 100 38 27.58% -29 -20.98% -8 -37 -31 -0.60
108.3Q 147 78 69 46.85% 6 3.96% 7 13 11 0.22
108.2Q 147 102 45 30.60% -18 -12.53% 11 -8 -13 -0.26
108.1Q 162 128 34 20.68% -36 -22.16% 4 -32 -26 -0.52
107.4Q 165 90 75 45.28% 1 0.64% 11 12 7 0.15
107.3Q 162 89 73 44.90% -2 -1.22% 26 24 43 0.83
107.2Q 157 83 75 47.53% 8 5.12% 38 46 38 0.73
107.1Q 182 78 104 57.12% 37 20.35% -20 17 16 0.34
106.4Q 172 76 95 55.45% -28 -16.17% -9 -37 -31 -0.66
106.3Q 162 67 95 58.66% 33 20.61% -11 23 20 0.42
106.2Q 151 64 86 57.25% 24 15.68% -9 14 10 0.22
106.1Q 152 70 82 53.86% 23 15.02% -16 6 5 0.11
105.4Q 177 76 101 57.15% 30 17.10% 41 72 56 1.27
105.3Q 183 94 89 48.39% 32 17.34% 3 35 27 0.61
105.2Q 165 70 95 57.60% 35 21.37% 19 54 45 1.07
105.1Q 176 71 105 59.63% 47 26.76% -5 42 33 0.78
104.4Q 164 69 95 58.12% 27 16.24% 4 31 42 0.95
104.3Q 163 73 90 55.26% 41 25.06% 20 61 50 1.14
104.2Q 160 74 86 53.82% 44 27.56% 1 46 36 0.82
104.1Q 157 64 93 59.31% 5 3.34% 2 7 21 0.47
103.4Q 152 334 -182 -119.68% -225 -147.71% 7 -217 -92 -2.30
103.3Q 168 87 81 48.23% 35 20.86% 6 41 36 0.91
103.2Q 149 64 85 57.13% 44 29.62% 2 47 38 0.98
103.1Q 185 100 85 46.11% 35 18.71% 9 44 38 0.97
102.4Q 153 60 93 60.83% 54 35.66% 10 64 56 1.43
102.3Q 139 59 80 57.54% 44 31.46% 1 45 39 1.00
102.2Q 139 52 87 62.55% 49 35.39% 5 54 43 1.09
102.1Q 145 59 85 59.08% 45 31.31% 5 50 43 1.10
以上資料僅供參考，本公司不負任何法律責任，投資人若依此以為買賣依據，須自負盈虧之責。
數據以台灣證券交易所與證券櫃檯買賣中心公告之內容為準。